SCHEMBL29469769

SCHEMBL29469769

NCc1cccc(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42451 1.00
SCHEMBL3401008 1.00 TAAR1 (0.68)
Bromide SCHEMBL4208477 0.98 TAAR1 (0.65)
Hydrochloric Acid SCHEMBL302987 0.98 TAAR1 (0.65)
Iodide SCHEMBL31162584 0.98 TAAR1 (0.65)
Iodide SCHEMBL28639359 0.98 TAAR1 (0.65)
SCHEMBL27944031 0.86 TAAR1 (0.53)
SCHEMBL235748 0.81 TAAR1 (1.00)
SCHEMBL10422276 0.81 LOXL2 (0.71)
SCHEMBL36008 0.81 LOXL2 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026105739-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, AND METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2026-05-21 WO disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
WO-2025089373-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, MOBILE BODY, AND BUILDING MATERIAL キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089368-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089402-A1 METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089395-A1 METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089411-A1 COMPOSITION, PREPARATION METHOD FOR COMPOSITION, AND PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089392-A1 PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089405-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, AND METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2025-05-01 WO disclosed
WO-2025089376-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, AND METHOD FOR MANUFACTURING PHOTOELECTRIC CONVERSION ELEMENT キヤノン株式会社 2025-05-01 WO disclosed
US-20240174782-A1 PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF MOLECULAR INSIGHT PHARM INC (US) 2024-05-30 US disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
US-11840592-B2 Preparations of meta-iodobenzylguanidine and precursors thereof MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2023-12-12 US disclosed
US-20230365546-A1 5-SUBSTITUTED INDOLE 3-AMIDE DERIVATIVES, PREPARATION METHOD AND USE THEREOF ORIGIANT PHARMACEUTICAL CO., LTD (CN) 2023-11-16 US disclosed
EP-4255425-A1 IMIDAZOLE COMPOUNDS AS INHIBITORS OF ENPP1 Stingray Therapeutics, Inc. (US) 2023-10-11 EP disclosed
EP-4212525-A1 5-SUBSTITUTED INDOLE 3-AMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF Origiant Pharmaceutical Co., Ltd (CN) 2023-07-19 EP disclosed
US-20230008878-A1 PREPARATIONS OF META-IODOBENZYLGUANIDINE AND PRECURSORS THEREOF CITIZENS BANK, N.A., AS COLLATERAL AGENT, NATIONAL BANKING ASSOCIATION 2023-01-12 US disclosed
EP-4100405-A1 MACROCYCLIC PAD4 INHIBITORS USEFUL AS IMMUNOSUPPRESSANT Bristol-Myers Squibb Company (US) 2022-12-14 EP disclosed
WO-2022119928-A1 IMIDAZOLE COMPOUNDS AS INHIBITORS OF ENPP1 Stingray Therapeutics, Inc. (US) 2022-06-09 WO disclosed
US-11279784-B2 Preparations of meta-iodobenzylguanidine and precursors thereof MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) 2022-03-22 US disclosed